Search      Advanced Search | Browse By Topic
Magazine Content
Home
Features
Columnists
Industry Risk Reports
In-Depth Series
Special Reports
Point/Counterpoint
R&I One® Content
News & Analysis
Editor's Choice Stories
Resources and Tools
Power Broker® Directory
Risk InnovatorTM
Emerging Risks
Top Employee Benefits Consultant
Executives To Watch
Insights
Industry Events
WorkersComp Forum
Award Nominations
Webinars
RSS
R&I Information
Subscription Center
Advertiser Information
About Us
Contact Us
 

Newsletter Sign-up

Click on the name of the free newsletter below to preview:

R&I One®
WORKERSCOMP Forum TM Update
HTML Text
E-Mail Address:


Click here to unsubscribe
Privacy Policy
Preferences

 

Insurance legislators to focus on physician dispensing repackaged drugs

One of the emerging cost drivers in the workers' comp system is repackaged drugs, mainly dispensed through physicians' offices. Estimates put the cost at between $700 million and $1 billion annually.

Print Email Add to Facebook Add to Twitter Add to LinkedIn Write to the Editor Reprints

Florida lawmakers are considering legislation to limit reimbursements for repackaged or relabeled prescription drugs. Other states, including Maryland, South Carolina, and Georgia, are looking at the problem. Texas lawmakers considered a bill that would have overturned the ban on physician dispensing.

Repackaged drugs are pharmaceuticals purchased in bulk by drug repackagers. They are often sold at higher profits.

In Florida, for example, reimbursement for prescription drugs is the average wholesale price plus a $4.18 dispensing fee, or contract rate, whichever is lower. Repackaged drugs are assigned a different AWP, which may be substantially higher than the manufacturer's AWP.

Critics say it is a hugely profitable industry that adds hundreds of millions of dollars to the workers' comp system unnecessarily. In a recent interview, Joseph Paduda, principal of Health Strategy Associates, said there is so much profit in the practice that the companies involved "will spend whatever it takes to keep their livelihood going."

State lawmakers will look at the issue when they gather for the spring meeting of the National Conference of Insurance Legislators in Mississippi. During its hourlong meeting, NCOIL's Workers' Compensation Insurance Committee will include a discussion of state physician dispensing and repackaged drug efforts.

Last November, NCOIL committee members chose it as one of the main cost-driving issues in the system warranting a close examination.

At the February meeting, members will hear from a broad spectrum of speakers, including:

  • Florida Insurance Commissioner Kevin McCarty will offer a regulator's perspective.
  • Insurance representatives from the American Insurance Association and the Property Casualty Insurers Association of American will offer their insights.
  • A representative from Concentra will provide the medical provider perspective.
  • The committee is also hoping to hear from someone from Automated Healthcare Solutions to get insight from the industry itself.

Following the spring meeting, NCOIL committee members will consider either developing model legislation for states in time for next November's meeting or may decide to continue exploring the issue.

Read more at the WorkersComp Forum homepage.

February 13, 2012

Copyright 2012© LRP Publications

 
 
 
 
 
 
 
 
 
 
 
RISK logo
 

Back to top

Entire contents copyright © 2013 Risk and Insurance® All rights reserved. May not be reproduced in any form without written permission.